Woolen Sean, Gemmete Joseph J
From the Departments of Radiology, University of Michigan Health System, UH B1D 328, 1500 East Medical Center Drive, Ann Arbor, MI 48109.
From the Departments of Radiology, University of Michigan Health System, UH B1D 328, 1500 East Medical Center Drive, Ann Arbor, MI 48109; Neurosurgery, University of Michigan Health System, UH B1D 328, 1500 East Medical Center Drive, Ann Arbor, MI 48109; Otolaryngology, University of Michigan Health System, UH B1D 328, 1500 East Medical Center Drive, Ann Arbor, MI 48109.
J Vasc Interv Radiol. 2016 Oct;27(10):1570-5. doi: 10.1016/j.jvir.2016.05.027.
This report presents 4 patients (mean age, 22 y; range, 17-26 y) with facial arteriovenous malformations (AVMs) who underwent arterial ethanol and N-butyl cyanoacrylate embolization followed by percutaneous cryoablation of residual inaccessible AVMs. After the procedure, minor complications classified as type B according to the Society of Interventional Radiology (SIR) classification system occurred in 75% (3/4) of patients. One patient achieved 90% obliteration of AVM, and 3 patients had complete obliteration of AVM at 1-year follow-up. This reports shows that percutaneous ablation may be a viable treatment option for residual facial AVMs after ethanol and glue embolization.
本报告介绍了4例面部动静脉畸形(AVM)患者(平均年龄22岁;范围17 - 26岁),这些患者接受了动脉内乙醇和氰基丙烯酸正丁酯栓塞,随后对残留的难以触及的AVM进行经皮冷冻消融。术后,根据介入放射学会(SIR)分类系统,75%(3/4)的患者出现了B型轻微并发症。1例患者的AVM闭塞率达到90%,3例患者在1年随访时AVM完全闭塞。本报告表明,经皮消融可能是乙醇和胶水栓塞后残留面部AVM的一种可行治疗选择。